Guy Oriol

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Biomerieux, Inc.. Active years: 1997-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guy Oriol. Retrieved from https://idiyas.com/inventor/guy-oriol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 83.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

6 out of 645

Biomerieux, Inc.

patents

Years Active: 1997-2018

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10040829 - Methods for producing peptides including HERV-W envelope motifs and for producing antibodies specific for the peptides (2018-08-07),

2. 7595180 - RNA-dependent RNA polymerase functioning preferably on a RNA matrix and promoter-dependent transcription process with said RNA-dependent RNA polymerase (2009-09-29),

3. RE39031 - RNA amplification method requiring only one manipulation step (2006-03-20),

4. 6828127 - Method of amplifying an RNA target sequence using an RNA polymerase functioning preferably on RNA template (2004-12-07),

5. 5817465 - RNA amplification method requiring only one manipulation step (1998-10-06),

6. 5654143 - RNA amplification method requiring only one manipulation step (1997-08-05),

Title: Guy Oriol: Innovator in Peptide and RNA Research

Introduction

Guy Oriol is a notable inventor based in Saint-Chamond, France. He has made significant contributions to the fields of peptide production and RNA transcription. With a total of 6 patents, his work has advanced the understanding and application of biotechnological processes.

Latest Patents

Oriol's latest patents include innovative methods for producing peptides that incorporate HERV-W envelope motifs. These methods detail a peptide domain essential for interaction between a virus envelope and an hASCT receptor. The domain consists of specific N-terminus and C-terminus motifs, along with additional motifs that facilitate this interaction. Furthermore, he has developed a process involving RNA-dependent RNA polymerase that functions on an RNA matrix. This process allows for RNA transcription using a nucleotide reagent as a promoter, enabling transcription without sequence specification and without the need for protein cofactors. His inventions are particularly applicable in the detection, synthesis, or quantification of RNA.

Career Highlights

Throughout his career, Guy Oriol has worked with prominent companies such as bioMérieux, Inc. and bioMérieux SA. His experience in these organizations has contributed to his expertise in the biotechnology sector.

Collaborations

Oriol has collaborated with notable professionals in his field, including Bernard F Mandrand and Francois Mallet. These partnerships have further enriched his research and development efforts.

Conclusion

Guy Oriol's innovative work in peptide and RNA research has positioned him as a key figure in biotechnology. His patents reflect a commitment to advancing scientific knowledge and practical applications in this vital area.

Profile summary based on public USPTO records.